Search

Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) caused by multiple factors. Studies have shown that epithelial cell damage was associated with ferroptosis in UC. Therefore, our research focused on the effects and mechanism of iron chelator deferasirox in UC. The UC model was induced by 2.5 % dextran sulfate sodium salt (DSS) and administered with deferasirox (10 mg/kg) for 7 days. Histological pathologies, inflammatory response, ferrous iron contents, oxidative stress and ferroptosis regulators were determined. Intestinal microbiota alteration and short-chain fatty acids (SCFAs) production were analyzed through 16S rRNA gene sequencing and targeted metabolomics. Deferasirox significantly relieved the DSS-induced UC in mice, as evidenced by weight loss, survival rate, colon length shortening disease activity index (DAI) score and histology score. Deferasirox treatment reduced the level of pro inflammatory cytokines (IL-1β, IL-6, TNF-α and INF-γ). Ferroptosis was induced in mice with UC, as evidenced by ferrous iron accumulation, increased ROS production, SOD and GSH depletion, decreased the expression of GPX-4 and FTH, accompanied by increased expression of TF. Deferasirox treatment strongly reversed the alterations caused by ferroptotic characteristics in DSS-induced mice. Moreover, deferasirox treatment reshaped the composition of intestinal microbiota. The results revealed the genera of norank_f__Muribaculaceae , Lachnospiraceae_NK4A136_group , Prevotellaceae_UCG-001 , Odoribacter and Blautia were increased distinctly, while Escherichia-Shigella and Streptococcus were significantly decreased by deferasirox treatment. Targeted metabolomics analysis indicated the SCFAs production enhanced in deferasirox-treated mice. Our results suggested that deferasirox could treat DSS-induced UC in mice by inhibiting ferroptosis and improving intestinal microbiota. [ABSTRACT FROM AUTHOR]

Magnesium hydride (MgH 2) has been proposed as a promising hydrogen storage material due to its high hydrogen capacity. However, its application is hindered by sluggish kinetics and high dehydrogenation temperature. Herein, we report the successful preparation of the Fe containing MgH 2 solid solution by milling method, and systematically investigate the dehydrogenation properties and mechanism of the composite through experiments and first principle calculations. The results show that the serious lattice distortion and charge transfer caused by Fe atoms lead to the instability of MgH 2 , significantly improving the dehydrogenation kinetics of MgH 2. As a result, the dehydrogenation activation energy of MgH 2 –Fe composite was successfully reduced by 44.5%. Notably, the initial dehydrogenation temperature of the composites is nearly 200 °C lower than that of pure MgH 2 , and 4.5 wt% of H 2 can be released at 230 °C for 30 min. These findings provide novel insights for designing simple, low-cost catalysts for MgH 2 synthesis. [Display omitted] • The Fe containing MgH 2 solid solution is prepared by milling method. • The dehydrogenation activation energy of Fe doped MgH 2 solid solution decreases significantly. • The Fe doped MgH 2 solid solution releases 2.5 wt% H 2 at 200 °C. • Lattice distortion and Mg–H instability caused by Fe atom solution. [ABSTRACT FROM AUTHOR]